See also this year's filing and all EDGAR filings for this company.
PDF Report 0001253689_2018_Crescent_Biopharma_INC.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001253689, Crescent Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 127,219,622 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,106,899 |
| 3 | remainder_Assets | 256,684 |
| 4 | LiabilitiesCurrent | 8,174,777 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 707,003 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,163,270 |
| 9 | ResearchAndDevelopmentExpense | 24,345,611 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 681 |
| 12 | remainder_NetIncome | 3,389,037 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 128,583,205 |
| 1 | Liabilities | 8,881,780 |
| 2 | Expenses | 34,508,881 |
| 3 | Revenues | 681 |
| 4 | StockholdersEquity | 119,701,425 |
| 5 | NetIncome | -31,119,163 |
| 6 | ComprehensiveNetIncome | -31,119,163 |
| 7 | BaseVar | 87,681,792 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.34 |
| 9 | EconomicCapitalRatio | 3.92 |